This inventor holds 1 USPTO granted patent. Top assignee: Shionogi Company Limited. Active years: 1988.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1988
Title: Hirotane Kagawa: Innovator in Anticancer Research
Introduction
Hirotane Kagawa is a prominent inventor based in Osaka, Japan. He holds a patent that contributes significantly to the field of oncology, particularly in the development of stable freeze-dried preparations for anticancer treatments.
Latest Patents
Kagawa's notable patent is titled "Stable freeze-dried preparations of an anticancer platinum complex." This innovative preparation, which includes glycolato-cis-diammineplatinum (II), employs stabilizers such as glucan, water-soluble vinyl polymer, and polyethylene glycol. The advancements made through this patent have proven very useful in treating various forms of cancer.
Career Highlights
Hirotane Kagawa is affiliated with Shionogi & Company Limited, a reputable pharmaceuticals entity known for its commitment to addressing healthcare challenges through innovative solutions. Kagawa’s work exemplifies the application of scientific research in developing effective treatments.
Collaborations
During his career, Kagawa has collaborated with talented individuals such as Kazuhiro Shima and Takayuki Tsukada. These partnerships have fostered an environment of creativity and innovation, enabling advancements in medical research and drug development.
Conclusion
Hirotane Kagawa's contributions to anticancer therapies underscore the importance of innovation in the medical field. His patent reflects his dedication to improving patient outcomes and showcases the vital role of inventors in advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile